← Leaderboards
Randall L Carpenter
Seaside Therapeutics, Llc
$6,442,170
Attributed
$7,524,567
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2007–19$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,524,567 · 2
By mechanism
U01$5,900,971 · 1
R42$1,623,596 · 1
Top collaborators
- Frank A Middleton3 shared
- Alexander Rajan3 shared
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadGrantPhenotypeScreening ProcedureBrainFutureGeneticPharmaceutical PreparationsClinical TrialsSymptomsAutistic DisorderExcretory FunctionFmr1AttentionAnxietyDrug KineticsEngineeringFmr1 GeneBasic ScienceCognitive FunctionAnimal ModelAnimalsDrug DevelopmentDesign
Grant awards (7)
Validation of a salivary miRNA diagnostic test for autism spectrum disorder$701,023
R42 · FY2019 · MH
Validation of a salivary miRNA diagnostic test for autism spectrum disorder$330,000
R42 · FY2019 · MH
Validation of a salivary miRNA diagnostic test for autism spectrum disorder$592,573
R42 · FY2018 · MH
Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism$1,068,100
U01 · FY2009 · MH · contact PI
Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism$2,587,460
U01 · FY2008 · MH · contact PI
Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism$1,068,100
U01 · FY2008 · MH · contact PI
Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism$1,177,311
U01 · FY2007 · MH · contact PI